Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database

Woo-Hyoung Kang; Shin Hwang; Jong Man Kim; Kwang-Woong Lee; Dong Jin Joo; Young Kyoung You; Je Ho Ryu; Bong-Wan Kim; Donglak Choi; Dong-Sik Kim; Yang Won Nah

doi:10.12659/AOT.936937

13 September 2022 : Original article

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database

Woo-Hyoung Kang

^1ABCDE, Shin Hwang^1ABCDEFG*, Jong Man Kim

^2BCE, Kwang-Woong Lee^3BDE, Dong Jin Joo^4BDE, Young Kyoung You^5BDE, Je Ho Ryu^6BCE, Bong-Wan Kim^7BDE, Donglak Choi^8BDE, Dong-Sik Kim

^9BDE, Yang Won Nah^10BDE

DOI: 10.12659/AOT.936937

Ann Transplant 2022; 27:e936937

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Comparison of alpha-fetoprotein (AFP; A) and protein induced by vitamin K absence or antagonist-II (PIVKA-II; B) levels according to the status of hepatocellular carcinoma (HCC) in all patients. Bars indicate 25–75 percentiles. C) Receiver operating characteristic curve analysis for diagnosis of HCC. AUC indicates the area under the curve.

Back to the Article

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database

Your Privacy